Prospecto: Information for the User
Itraconazol Alter 100 mg Hard Capsules EFG
Read this leaflet carefully before you start taking this medicine, because it contains important information for you
Itraconazol Alter belongs to the group of medicines called “antifungals”.
It is indicated for the treatment of infections caused by fungi of the vagina, skin, mouth, eyes, nails, or internal organs.
Do not take Itraconazol Alter 100 mg capsules
If your doctor thinks you should take this medicine, contact him immediately if you notice that you are short of breath, gain weight unexpectedly, have swollen legs, feel unusually tired, or start waking up at night.
Inform your doctor if you are taking any other medicine.
Do not use Itraconazol Alter ifyou are taking any of the following medicines, or within 2 weeks of the end of Itraconazol Alter treatment:
Medicines used to treat heart, blood, or circulation problems
Medicines to treat stomach or constipation problems
Medicines to treat headache, sleep, or mental health problems
Medicines to treat urinary problems
Medicines to treat allergies
Medicines to treat erection and ejaculation problems
Other medicines that contain:
Remember: do not take any of the above medicines during 2 weeks after your last treatment with Itraconazol Alter.
Warnings and precautions
Be especially careful with Itraconazol Alter
Other medicines and Itraconazol Alter
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine, including those purchased without a prescription.
There are medicines thatshould not be takenwhile takingItraconazol Alter. These medicines are listed above under the heading “Do not use Itraconazol Alter”
Do not use certain medicines with Itraconazol Alter
Your doctor may decide thatyou should not take some medicines at the same time as Itraconazol Alter or within 2 weeks after its completion.
Examples of these medicines are:
Medicines used to treat heart, blood, or circulation problems
Medicines to treat epilepsy, headache, or mental health problems
Medicines to treat urinary problems
Medicines to treat cancer
Medicines to treat tuberculosis
Medicines to treat HIV or hepatitis
Medicines used after organ transplantation
Medicines to treat benign prostatic hyperplasia
Medicines to treat respiratory, allergy, or inflammatory problems
Medicines to treat erection and ejaculation problems
Other medicines that contain:
Remember: do not take any of the above medicines during 2 weeks after your last treatment with Itraconazol Alter.
This list is not exhaustive, so you should inform your doctor if you are taking or plan to take any of these medicines or any other medicine.
Be careful when using Itraconazol Alter 100 mg with certain medicines.
You may be more likely to experience side effects or the dose of Itraconazol Alter or the other medicine may need to be adjusted. Examples of these medicines are:
Medicines used to treat heart, blood, or circulation problems
Medicines to treat stomach or diarrhea problems
Medicines to treat sleep or mental health problems
Medicines to treat urinary problems
Medicines to treat cancer
Medicines to treat infections
Medicines to treat HIV or hepatitis
Medicines used after organ transplantation
Medicines to treat benign prostatic hyperplasia
Medicines to treat respiratory, allergy, or inflammatory problems
Medicines to treat erection and ejaculation problems
Medicines to treat pain
Other medicines that contain:
This list is not exhaustive, so you should inform your doctor if you are taking or plan to take any of these medicines, or any other medicine, so that appropriate measures can be taken.
You should have enough acidity in the stomach to ensure the absorption of Itraconazol Alter capsules. Therefore, medicines that neutralize stomach acidity should be taken at least 2 hours before taking itraconazole or 2 hours after taking this medicine. For the same reason, if you are taking medicines that regulate stomach acid production, take Itraconazol Alter with a cola drink (see section 3 “How to take Itraconazol Alter”).
In case of doubt, consult your doctor or pharmacist.
Taking Itraconazol Alter with food and drinks
Take this medicine immediately after finishing one of the main meals..
If you are taking any medicine that regulates stomach acid production, it is recommended to take this medicine with a cola drink.
Pregnancy and breastfeeding
If you are pregnant or breastfeeding, or think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine
Pregnancy
Itraconazol Alter will not be used during pregnancy.
If you are fertile and may become pregnant, consult your doctor. You should use effective contraceptive measures to avoid becoming pregnant during treatment. Because Itraconazol Alter may remain in the body for a long time, you should prolong contraceptive measures until the next menstrual period after completing treatment with this medicine. (See section 2 “Do not take Itraconazol Alter”).
Breastfeeding
If you are breastfeeding, consult your doctor before taking Itraconazol Alter, as small amounts of the medicine may appear in milk.
Driving and operating machinery
Itraconazol Alter may cause dizziness, blurry vision, or hearing loss. If you experience any of these symptoms, do not drive or operate machinery.
Itraconazol Alter contains saccharose
This medicine contains saccharose. If your doctor has told you that you have an intolerance to certain sugars, consult him before taking this medicine.
Follow exactly the administration instructions of Itraconazol Alter indicated by your doctor. Consult your doctor or pharmacist if you have doubts. Remember to take your medication.
Your doctor will indicate the duration of your treatment with this medication. Do not suspend the treatment before. If you estimate that the medication's action is too strong or weak, inform your doctor or pharmacist.
You must take Itraconazol Alter immediately after meals, as it is absorbed better. Swallow the capsules whole with a little water. The number of capsules you should take and for how long depends on the type of fungus and the location of the infection. Your doctor will tell you exactly how much itraconazole you should take.
There must be enough acidity in the stomach to ensure the absorption of this medication. Therefore, medications that neutralize stomach acidity should be used two hours after taking this medication or two hours before taking Itraconazol Alter capsules. For the same reason, if you are taking medications that regulate acid production in the stomach, take Itraconazol Alter with a cola drink.
The following doses are the most frequent:
TYPE OF INFECTION | CAPSULES PER DAY | DURATION |
Vaginal infection | 2 capsules twice a day or 2 capsules once a day | 1 day 3 days |
Skin infection | 2 capsules once a day or 1 capsule once a day | 7 days 2 weeks |
If the palms of the hands or the soles of the feet are affected, 2 capsules twice a day for 7 days or 1 capsule once a day for 1 month may be needed. | ||
Mouth infections | 1 capsule once a day | 2 weeks |
Eye infections | 2 capsules once a day | 3 weeks |
Internal infections | 1 to 4 capsules daily | Longer periods |
-Continuous treatment for foot nail infections:
TYPE OF INFECTION | CAPSULES PER DAY | DURATION |
Continuous treatment for nails | 2 capsules once a day | 3 months |
-Pulsatile treatment for nails:
This consists of 2 capsules twice a day for 1 week; then stop taking itraconazole capsules for 3 weeks. The cycle is then repeated, once for the hands and twice for the feet (with or without infection in the hands).(See the following table)
Week 1 | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | Week 7 | Week 8 | Week 9 | Week 10 | |
Fingernails of the feet with or without hand nail infection | Take 2 capsules twice a day | No treatment with Itraconazol Alter capsules | Take 2 capsules twice a day | No treatment with Itraconazol Alter capsules | Take 2 capsules twice a day | Interru mpir the tratami ento | ||||
Only hand nails | Take2 capsules twice a day | No treatment with Itraconazol Alter capsules | Take 2 capsules twice a day | Interrumpir the tratami ento |
In skin infections, lesions will disappear a few weeks after treatment is completed. This is characteristic of fungal spots: the medication eliminates the fungus itself, but the lesion does not disappear until new skin grows.
Fingernail lesions will disappear from 6 to 9 months after treatment is completed, as the medication only eliminates the fungus itself. The nail must grow, which takes several months. Therefore, do not worry if you do not notice improvement during treatment: the medication remains in your nails for several months and fulfills its mission. Therefore, you must interrupt treatment at the time indicated by your doctor, even if you do not see any improvement.
Internal organ infections:Higher doses may be needed and for a long time. Always follow your doctor's instructions, as they will adapt the treatment to your needs.
Use in Children
Itraconazole capsules should not be used in children. Only in exceptional cases can it be prescribed by the doctor.
If you take more Itraconazol Alter than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or the Toxicological Information Service, Teléfono 91 562 04 20, indicating the medication and the amount used.
In case of accidental overdose, your doctor will apply supportive measures. Itraconazole is not eliminated by hemodialysis. No specific antidotes are known.
If you forget to take Itraconazol Alter
If you forget to take the medication, take the next dose that corresponds to you and continue treatment as indicated by your doctor. Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Itraconazol Alter
Do not interrupt treatment with itraconazole without consulting your doctor, as the symptoms of your disease may reappear or worsen.
If you have any other doubts about the use of this medication, ask your doctor or pharmacist.
Like all medicines, Itraconazol Alter may cause side effects, although not everyone will experience them.
If you consider that any of the side effects you are experiencing are severe or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.
The following side effects have been seen during the marketing of the medicine and clinical trials.
Adverse reactions were classified by frequency using the following convention:
Very common: may affect more than 1 in 10 people
Common: may affect up to 1 in 10 people
Uncommon: may affect up to 1 in 100 people Rare: may affect up to 1 in 1,000 people
Very rare: may affect up to 1 in 10,000 people
Frequency not known: cannot be estimated from available data
Uncommon: sinusitis (irritation and swelling of the nasal sinuses), upper respiratory tract infection, rhinitis (inflammation of the nasal mucosa with watery discharge and frequent sneezing)
Rare: leucopenia
Uncommon: hypersensitivity and allergic reactions
Rare: anaphylactic reactions (allergic reactions), serum sickness (allergy that appears after the injection of some sera, characterized by the appearance of urticaria, accumulation of fluid, joint pain, fever, and extreme exhaustion), angioneuritic edema (swelling due to fluid accumulation that may affect the mouth and upper respiratory tract)
Rare: increased triglycerides
Common: headache
Rare: tremor, sensation of numbness in the extremities (paresthesia), decreased sensitivity (hypoaesthesia), unpleasant taste (bad taste)
Rare: visual disturbances (including blurred vision and double vision)
Rare: permanent or temporary hearing loss, subjective sensation of noise in the ear
Rare: congestive heart failure
Rare: dyspnea (shortness of breath), difficulty breathing
Common: abdominal pain, nausea
Uncommon: vomiting, discomfort associated with meals, diarrhea, constipation, flatulence (accumulation of gas in the intestine)
Rare: pancreatitis (inflammation of the pancreas)
Uncommon: abnormal liver function
Rare: elevated bilirubin in blood (hyperbilirubinemia), severe hepatotoxicity (including cases of acute severe liver failure)
Uncommon: urticaria, rash, pruritus
Rare: toxic epidermal necrolysis (severe skin disease characterized by skin rash and the appearance of blisters and scales), Stevens-Johnson syndrome (severe skin, mucous membrane, and eye inflammation), a severe skin disorder (generalized exfoliative dermatitis with skin peeling and blisters in the mouth, eyes, and genitals, or generalized exfoliative dermatitis with small pustules or blisters), erythema multiforme (skin disease characterized by the appearance of vesicles, blisters, etc.), dermatitis exfoliativa (skin disease characterized by peeling), leukocytoclastic vasculitis (inflammation of the blood vessel walls), alopecia (hair loss), photosensitivity (exaggered skin response to sunlight)
Rare: increased frequency of urination
Uncommon: menstrual disorders
Rare: erectile dysfunction
Rare: edema (fluid accumulation)
Rare: increased creatine phosphokinase in blood (parameter that measures liver function)
Description of certain side effects
The following side effects are associated with itraconazole notified in clinical trials of itraconazole oral solution and/or intravenous, excluding the side effect "inflammation at the injection site" since this side effect is specific to the intravenous administration route.
Immune system disorders: anaphylactoid reaction
Psychiatric disorders: sensation of confusion or disorientation
Cardiac disorders: heart failure, left ventricular insufficiency, tachycardia (rapid heart rate)
Respiratory, thoracic and mediastinal disorders: pulmonary edema, hoarseness, cough
Hepatobiliary disorders: liver insufficiency, hepatitis, jaundice (yellowing of the skin, eyes, mucous membranes, and secretions)
Musculoskeletal and connective tissue disorders: muscle pain or weakness (myalgia), joint pain (arthralgia)
General disorders and administration site conditions: generalized edema (excessive fluid accumulation in the body), facial edema (fluid accumulation in the face), chest pain, fever, pain, fatigue, chills
Side effects in the pediatric population
Based on clinical trial data in pediatric patients, the most frequently reported side effects were: headache, vomiting, abdominal pain, diarrhea, abnormal liver function, low blood pressure, nausea, and urticaria.
In general, the nature of the side effects is similar to that observed in adult patients, although the incidence is higher in pediatric patients.
If you experience any of these side effects, consult your doctor.
If you consider that any of the side effects you are experiencing are severe or if you notice any side effect not mentioned in this leaflet, inform your doctor or pharmacist.
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this leaflet. You can also report them directly through the Spanish System for Pharmacovigilance of Medicines for Human Use: https://www.notificaram.es By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use Itraconazol Alter after the expiration date that appears on the packaging. The expiration date is the last day of the month indicated.
Do not store at a temperature above 30°C.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection point at the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. By doing so, you will help protect the environment.
Composition of Itraconazol Alter
Sugar spheres (cornstarch and sucrose), poloxamer 188, hypromellose.
Capsule coating: indigo carmine (E-132), quinoline yellow (E-104), titanium dioxide (E-171), and gelatin.
Appearance of the product and contents of the packaging
Itraconazol Alter 100 mg capsules are available in packaging of 7, 14, or 100 (clinical packaging) hard capsules in aluminum/aluminum blisters.
Only some package sizes may be commercially available.
Marketing authorization holder and manufacturer responsible: Marketing authorization holder:
Laboratorios Alter, S.A
C/ Mateo Inurria, 30
28036 Madrid
Spain
Manufacturer responsible:
Laboratorios Liconsa, S.A. Avda. Miralcampo, Nº 7, Industrial Estate Miralcampo
19200 Azuqueca de Henares (Guadalajara)
Spain
Last review date of this leaflet: July 2021
The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS)http://www.aemps.gob.es/
Есть вопросы по этому лекарству или вашим симптомам? Свяжитесь с лицензированным врачом для получения помощи и персонализированного ухода.